WEST ORANGE, N.J. — Everett Laboratories Inc. has released Pregnitude, a reproductive support dietary supplement for women having difficulty conceiving.

The company said Monday that the Pregnitude, available without a prescription at most major retail pharmacies and found behind the pharmacy counter, has been shown in clinical studies to help support ovulation function and menstrual cycle regularity and the quality of a woman’s eggs.

A powder formulation mixed with water and taken twice daily, Pregnitude contains myo-inositol (2 g) and folic acid (200 mcg). According to Everett, myo-inositol is a naturally occurring substance produced in the human body that belongs to the vitamin B complex group and is found naturally in many foods such as fruits, cereals with high bran content, nuts and beans. Both myo-inositol and folic acid are considered key nutrients for women trying to become pregnant.

"With Pregnitude, we’re thrilled to provide a new option to support women who are having difficulty conceiving. We are confident that obstetricians and gynecologists around the country will find this a valuable alternative for women to support the ovulation frequency, regularity and quality of eggs," stated Lucas Sigman, chief executive officer of Everett Labs.

Everett noted that about 6.1 million U.S. women have difficulty getting pregnant, according to the Centers for Disease Control and Prevention (CDC).

"There is a tremendous need for support of couples having difficulty conceiving," commented Scott Eder, M.D., medical director at Everett Labs and a board-certified obstetrician and gynecologist. "They’re often left frustrated and anxious, and the stress can compound the problem. Pregnitude can help support ovulation function, menstrual cycle regularity and quality of eggs during this difficult time."